Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
79.8M
-
Shares change
-
+15.7M
-
Total reported value, excl. options
-
$401M
-
Value change
-
+$78.8M
-
Number of buys
-
40
-
Number of sells
-
-4
-
Price
-
$5.03
Significant Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q4 2022
54 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.8M shares
of 176M outstanding shares and own 45.26% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22.4M shares), FMR LLC (6.35M shares), JANUS HENDERSON GROUP PLC (5.94M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.77M shares), Rock Springs Capital Management LP (5.33M shares), Blackstone Inc. (4.62M shares), Foresite Capital Management V, LLC (4.4M shares), VANGUARD GROUP INC (3.61M shares), Vivo Capital, LLC (3.56M shares), and CHI Advisors LLC (2.83M shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.